Costs of home-based respiratory support and oxygen therapy

Objective. To assess the direct costs associated with home-based respiratory support and oxygen therapy (RSOT). Material and methods. The study included two stages: prospective follow-up of patients receiving home-based RSOT and economic analysis of results. There were 98 patients (mean age 61 years, 56.9% men) divided into 3 groups depending on home-based RSOT: invasive mechanical ventilation (IMV) — 8 (8.2%), non-invasive ventilation (NIV) — 43 (43.9%) and long-term oxygen therapy (LTOT) — 47 (47.9%). Direct costs of home-based RSOT were estimated. Results. The weighted average monthly expenses per patient with chronic respiratory failure (CRF) requiring RSOT at home were RUR 115.046 (95% CI: RUR 120.374 — 109.717) for IMV, RUR 39.905 (95% CI: RUR 44.336 — RUR 35.473) for NIV and RUR 10.518 (95% CI: RUR 11.128 — RUR 9.909) for LTOT. Most of these costs were related to provision of necessary equipment. Conclusion. Direct costs for home-based RSOT decrease sequentially from IMV to NIV and LTOT.

Authors

Institutions

Publication Details

Journal
Medical Technologies Assessment and Choice
Published
2025-09-09
DOI
https://doi.org/10.17116/medtech20254703193
Primary Topic
Respiratory Support and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Costs of home-based respiratory support and oxygen therapy

Sergey Nikolaevich Avdeev, M. Avxentyeva, И. С. Крысанов, E.S. Larin et al.
Medical Technologies Assessment and Choice
Respiratory Support and Mechanisms
article

Costs of home-based respiratory support and oxygen therapy

Sergey Nikolaevich Avdeev, M. Avxentyeva, И. С. Крысанов, E.S. Larin, А. О. Быков, Galiya S. Nuralieva, V. V. Tkachenko, D. V. Nevzorovа, K. A. Krokhin, А. Н. Комаров, B. E. Pervozvanskiy
article en

Abstract

Objective. To assess the direct costs associated with home-based respiratory support and oxygen therapy (RSOT). Material and methods. The study included two stages: prospective follow-up of patients receiving home-based RSOT and economic analysis of results. There were 98 patients (mean age 61 years, 56.9% men) divided into 3 groups depending on home-based RSOT: invasive mechanical ventilation (IMV) — 8 (8.2%), non-invasive ventilation (NIV) — 43 (43.9%) and long-term oxygen therapy (LTOT) — 47 (47.9%). Direct costs of home-based RSOT were estimated. Results. The weighted average monthly expenses per patient with chronic respiratory failure (CRF) requiring RSOT at home were RUR 115.046 (95% CI: RUR 120.374 — 109.717) for IMV, RUR 39.905 (95% CI: RUR 44.336 — RUR 35.473) for NIV and RUR 10.518 (95% CI: RUR 11.128 — RUR 9.909) for LTOT. Most of these costs were related to provision of necessary equipment. Conclusion. Direct costs for home-based RSOT decrease sequentially from IMV to NIV and LTOT.

Medical Technologies Assessment and ChoiceVol. 47(3)
Sechenov University (RU), Pirogov Russian National Research Medical University (RU), National Centre for Social research (GR), Scientific Research Institute of Healthcare Organization and Medical Management (RU), Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" (RU), Medical Technologies (Czechia) (CZ)
Openalex Percentile: Top 65%
Respiratory Support and Mechanisms
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.